Is GSK up or down today?
GSK is down 1.05% today, last at 53.15. This stock moved -1.05% versus the prior close.
GSK · GSK
GSK (GSK) is trading at 53.15, down 1.05% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 44 headlines skew mixed. Earnings and Analyst Rating themes dominated coverage. Stories with measurable price impact averaged -4.30% — headlines dragged the stock.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
GSK is down 1.05% today, last at 53.15. This stock moved -1.05% versus the prior close.
Over the past 7 days, 44 headlines skew mixed. Earnings and Analyst Rating themes dominated coverage. Stories with measurable price impact averaged -4.30% — headlines dragged the stock. Dominant story: GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving Plan - Yahoo! Finance Canada (3 sources, bullish) RSI is 55 — leaning bullish Price above 50-day average — short-term uptrend Social (demo): 40% of recent mentions lean bullish — social mood is cautious.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 10,330 mentions over 30d
GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving Plan
GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving Plan - tradingview.com
GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving Plan - Yahoo! Finance Canada
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push - biopharmadive.com
GSK Looks 19.3% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocus